HRT Financial’s DA32 Life Science Tech Acquisition Corp DALS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-17,372
Closed -$178K – 3410
2023
Q2
$178K Sell
17,372
-68
-0.4% -$694 ﹤0.01% 1874
2023
Q1
$176K Buy
17,440
+500
+3% +$5.04K ﹤0.01% 1950
2022
Q4
$168K Hold
16,940
– – ﹤0.01% 1978
2022
Q3
$164K Hold
16,940
– – ﹤0.01% 2270
2022
Q2
$164K Buy
16,940
+193
+1% +$1.88K ﹤0.01% 2310
2022
Q1
$163K Buy
+16,747
New +$162K ﹤0.01% 2542

HRT Financial's DALS Position: Q3 2023 in Review

HRT Financial sold out of DA32 Life Science Tech Acquisition Corp (DALS) in Q3 2023, closing a stake of 17,372 shares — an estimated $178K sold.

HRT Financial first reported a position in DALS in Q1 2022 and held it in 6 quarters. The position peaked at $178K in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

  • HRT Financial reported no remaining DA32 Life Science Tech Acquisition Corp position as of Q3 2023 after selling out during the quarter.
  • HRT Financial sold 17,372 DA32 Life Science Tech Acquisition Corp shares in Q3 2023, an estimated $178K.
  • HRT Financial first reported a position in DA32 Life Science Tech Acquisition Corp in Q1 2022 and held it in 6 quarters.
  • HRT Financial's DA32 Life Science Tech Acquisition Corp position peaked at $178K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp as of Q3 2023.

Based on HRT Financial's 13F filing for Q3 2023, filed 13 Nov 2023.